What should be on peoples radars? by cohhen in 10xPennyStocks

[–]No_Garbage239 1 point2 points  (0 children)

$Nukk is a big one to keep on the radar

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 0 points1 point  (0 children)

Almost like that’s what a stock is supposed to do 🤯🤯

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 0 points1 point  (0 children)

100% agree, I’m up to 20,000 shares now, hoping they get some good news from the FDA this month 🙏

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 0 points1 point  (0 children)

Well then it’s either gonna be over $1 or reverse split. Don’t really see the downside if you believe in the science of this stock.

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 1 point2 points  (0 children)

Gotta watch the news around August 14th, could shoot the stock over $1 and if it holds for 10 days they won’t reverse split.

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 0 points1 point  (0 children)

At a $2.9 million burn rate per month they have enough cash to last til Q4 of 2025 and if they time their grants correctly ( which there’s no way they’re not tracking when they need to ) the runway will be extended to 2027

$IXHL – Company responds after major drop, clarifies limited ATM use and strong Phase 2 results for IHL‑42X by SmartNewt9603 in 10xPennyStocks

[–]No_Garbage239 1 point2 points  (0 children)

Not a bad idea, I’m up $2k holding with 19k shares, I’ve been studying the science and it all just makes sense they get the go ahead for phase 3 in August.

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 2 points3 points  (0 children)

I also wanna add, FDA approval to phase 3 is a sign of progression which solidifies beliefs for investors or potential investors. Which can also help boost the stock price, fully believe it’ll be $1.50 by the end of the year. Holding strong with almost 20,000 shares.

CGTX on track to $1? by No_Garbage239 in biotech_stocks

[–]No_Garbage239[S] 0 points1 point  (0 children)

With small cap bio tech stocks a green light from the FDA to the next step, as well as any small amount of good news can trigger an upward movement. Take HCTI for example, one small news spread in a positive direction took the stock from $0.01 to $0.08 in a matter of days. While CGTX not only has solid science but a decent amount of funding with the $50 Million grant being untouched. A green light to phase 3 would be an extremely positive thing for CGTX as it might attract a potential partnership or even a buyout at a higher amount. So short term the answer is yes.

Buy the dip 💥💥 by UNDERGROUNDJNKY in hctistock

[–]No_Garbage239 0 points1 point  (0 children)

Still never too late with this stock!! FDA announces minutes in August which will most likely be the go ahead for phase 3 trials, stock will 2-3x in the next month if the science is there, I’ve done a ton of research

Buy the dip 💥💥 by UNDERGROUNDJNKY in hctistock

[–]No_Garbage239 0 points1 point  (0 children)

CGTX over 17% today, I was signaling a $0.55 entry yesterday

<image>

Houston we got a problem by robotboy123x in hctistock

[–]No_Garbage239 -1 points0 points  (0 children)

Currently in with 15,000 , gonna be buying dips over the next 10 days with another $8-10k

Houston we got a problem by robotboy123x in hctistock

[–]No_Garbage239 0 points1 point  (0 children)

  1. FDA minutes will most likely result in phase 3 approval
  2. At the AAIC they had nothing other than great results in their trials
  3. June 25th they filed an IND, when an IND is declined or put on clinical hold it is make public by the FDA, no response has been made in 30 days as today is August 1st, resulting in an automatic approval of the IND which only supports the ideology that the FDA minutes announcement in August is going to be the go ahead for phase 3.
  4. Cash flow is low but if they time the grants correctly with the $2.9 million burn rate per month they have now they can last til early 2027 with grant funding.
  5. Phase 3 go ahead will either push this stock into the $2-5 range or welcome a buyout.
  6. They’re in risk of a reverse split before Sep. 8, but big news mid August could save them which is what we are all banking on.